Sektor BB Biotech AG

Aktien

A0NFN3

CH0038389992

BION

Biotechnologie

Markt geschlossen - Swiss Exchange 17:31:24 17.02.2026 % 5 Tage Veränd. 1. Jan.
46.25 CHF +2.66% Intraday Chart für BB Biotech AG +0.22% +2.89%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. % 1 Jahr Veränd. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Kap.($)
+2.66%+0.22%-4.44%+8.31%+2.89%+21.07%-18.86%-49.06%-1.76% 3.3 Mrd.
+1.71%+3.79%-4.11%-0.59%-0.30%-10.90%-3.28%-12.01%+267.26% 48.77 Mrd.
+2.54%+0.40%+4.93%-5.78%+16.80%+53.71%+52.92%-0.74%+1’261.70% 39.27 Mrd.
-0.21%+4.62%+13.88%+25.33%+31.49%+36.37%+68.00%-14.25%+226.48% 36.05 Mrd.
-1.50%-9.87%-30.81%-23.91%-27.05%-14.99%-25.16%-12.96%+160.31% 27.89 Mrd.
+4.46%+4.82%-16.35%+45.52%+26.32%+147.38%+293.16%+114.47% - 19.45 Mrd.
+1.12%+18.33%+15.09%+144.16%+50.33%+31’885.82%+4’335.23% - - 15.61 Mrd.
+2.26%-2.11%-8.46%+12.43%+5.80%+33.00%-2.80%-19.06%+122.25% 13.78 Mrd.
+3.28%-0.35%+8.54%+3.16%+4.77%+55.06%+91.52%+32.83%+1’114.18% 13.71 Mrd.
+0.94%-3.48%+6.59%+11.06%+2.84%+162.11%+110.78%+39.55%+110.02% 13.18 Mrd.
+0.04%-4.01%-29.91%-26.90%-23.76%+25.87%+107.39%+158.78% - 12.15 Mrd.
-3.27%-4.54%+2.50%+4.97%+3.01%+16.18%-8.59%-20.79%+97.40% 10.05 Mrd.
+0.37%+6.93%+5.68%+11.11%-10.30%+1’546.34%+1’551.38%+238.03%+672.53% 9.94 Mrd.
-2.39%-9.72%-14.81%-0.19%-0.53%-11.28%-22.99%-42.54%+166.61% 9.15 Mrd.
+1.17%-5.94%-25.27%-20.83%-10.99%-41.23% - - - 9.35 Mrd.
+3.40%+2.36%+3.40%+66.03%+11.30%+261.40%+532.06%-57.19% - 9.1 Mrd.
-1.75%-12.53%-27.84%-2.59%-20.53%+4.30%-36.53%-47.06%+116.28% 7.8 Mrd.
-2.70%-3.52%-6.39%+0.34%+5.17%+8.06%-29.67%-56.60% - 7.34 Mrd.
-4.90%-8.59%+0.26%+9.54%+7.37%+9.97%-46.46%-68.02%+219.30% 7.23 Mrd.
-4.71%-38.69%-51.47%-43.37%-51.37%-52.41%-61.06%-57.19%+28.30% 6.77 Mrd.
Durchschnitt +0.22%-2.95%-7.95%+10.89%+1.16%+1’706.79%+362.48%+7.01%+325.78% 15.99 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung +0.87%-0.67%-5.03%+10.97%+5.42%+1’638.25%+320.99%+9.49%+427.29%
Biotechnologie und medizinische Forschung - Andere
  1. Börse
  2. Aktien
  3. A0NFN3 Aktie
  4. Sektor BB Biotech AG